# C_2007228EN.01001101.xml

| 28.9.2007 | EN | Official Journal of the European Union | C 228/11 |
| --- | --- | --- | --- |

28.9.2007

EN

Official Journal of the European Union

C 228/11

---

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 August 2007 to 31 August 2007

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council
   (1)
  or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council
   (2)
  )

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council

1

or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council

2

)

(2007/C 228/03)

—   Issuing, maintenance or modification of a national marketing authorisation

| Date of the decision | Name(s) of the medicinal product | Holder(s) of the marketing authorization | Member State concerned | Date of notification |
| --- | --- | --- | --- | --- |
| 3.8.2007 | INCRELEX | Tercica Europe Limited |
| 2 Harbourmaster Place |
| International Financial Services Centre |
| Dublin 1 |
| Ireland |

Date of the decision

Name(s) of the medicinal product

Holder(s) of the marketing authorization

Member State concerned

Date of notification

3.8.2007

INCRELEX

Tercica Europe Limited

2 Harbourmaster Place

International Financial Services Centre

Dublin 1

Ireland

This Decision is addressed to the Member States

6.8.2007

22.8.2007

Cefuroximaxetil

See Annex

See Annex

23.8.2007

28.8.2007

Abseamed

| Medice Arzneimittel Pütter GmbH & Co KG |
| --- |
| Kuhloweg 37 |
| D-58638 Iserlohn |

Medice Arzneimittel Pütter GmbH & Co KG

Kuhloweg 37

D-58638 Iserlohn

This Decision is addressed to the Member States

31.8.2007

28.8.2007

Binocrit

| Sandoz GmbH |
| --- |
| Biochemiestraße 10 |
| A-6250 Kundl |

Sandoz GmbH

Biochemiestraße 10

A-6250 Kundl

This Decision is addressed to the Member States

31.8.2007

28.8.2007

Epoetin alfa hexal

| HEXAL Biotech Forschungs GmbH |
| --- |
| Industriestraße 25 |
| D-83607 Holzkirchen |

HEXAL Biotech Forschungs GmbH

Industriestraße 25

D-83607 Holzkirchen

This Decision is addressed to the Member States

3.9.2007

---

(1)  OJ L 311, 28.11.2001, p. 67.

1

(2)  OJ L 311, 28.11.2001, p. 1.

2

---

ANNEX

LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDER/APPLICANTS IN THE MEMBER STATES

| Member State | Marketing Authorisation Holder | Applicant | Invented name | Strength | Pharmaceutical Form | Route of administration |
| --- | --- | --- | --- | --- | --- | --- |
| The Netherlands | Sandoz B.V. |
| Veluwezoom 22 |
| 1327 Almere |
| Nederland |

Member State

Marketing Authorisation Holder

Applicant

Invented name

Strength

Pharmaceutical Form

Route of administration

The Netherlands

Sandoz B.V.

Veluwezoom 22

1327 Almere

Nederland

Cefuroximaxetil 125, omhulde tabletten 125 mg

125 mg

Coated tablets

Oral use

Cefuroximaxetil 250, omhulde tabletten 250 mg

250 mg

Cefuroximaxetil 500, omhulde tabletten 500 mg

500 mg

Estonia

| 1A Pharma GmbH |
| --- |
| Keltenring 1 + 3 |
| D-82041 Oberhaching |

1A Pharma GmbH

Keltenring 1 + 3

D-82041 Oberhaching

Cefuroxim 1A Pharma 125 mg

125 mg

Coated tablets

Oral use

Cefuroxim 1A Pharma 250 mg

250 mg

Cefuroxim 1A Pharma 500 mg

500 mg

Greece

| Sandoz GmbH |
| --- |
| Biochemiestraße 10 |
| A-6250 Kundl |

Sandoz GmbH

Biochemiestraße 10

A-6250 Kundl

Cefuroxime axetil Sandoz 250 mg

250 mg

Coated tablets

Oral use

Cefuroxime axetil Sandoz 500 mg

500 mg

Portugal

| Sandoz Farmacêutica Lda. |
| --- |
| Alameda da Quinta da Beloura |
| Edifício 1-Esc. 15 |
| P-2710-693 Sintra |

Sandoz Farmacêutica Lda.

Alameda da Quinta da Beloura

Edifício 1-Esc. 15

P-2710-693 Sintra

Cefuroxima Sandoz 250 mg comprimidos

250 mg

Coated tablets

Oral use

Cefuroxima Sandoz 500 mg comprimidos

500 mg

Spain

| Sandoz Farmacéutica, S.A. |
| --- |
| Gran Vía de les Corts Catalanes, 764 |
| E-08013 Barcelona |

Sandoz Farmacéutica, S.A.

Gran Vía de les Corts Catalanes, 764

E-08013 Barcelona

Cefuroxima Sandoz 125 mg comprimidos recubiertos con película EFG

125 mg

Coated tablets

Oral use

Cefuroxima Sandoz 250 mg comprimidos recubiertos con película EFG

250 mg

Cefuroxima Sandoz 500 mg comprimidos recubiertos con película EF

500 mg

---